Radiofrequência Microfracionada na Síndrome Genitourinária da Menopausa
Palavras-chave:
fractional radiofrequency, geniturinary syndrome, vaginal atrophyReferências
Tadir Y, Iglesia C, Alexiades M, Davila GW, Guerette N, Gaspar A. Energy-based treatment for gynecologic conditions including genitourinary syndrome of menopause: Consensus, controversies, recommendations, and FDA clearance. Lasers Surg Med. 2019 Apr;51(4):315-317. doi: 10.1002/lsm.23031.
Kamilos MF, Borrelli CL. New therapeutic option in genitourinary syndrome of menopause: pilot study using microablative fractional radiofrequency. Einstein (Sao Paulo). 2017 Oct-Dec;15(4):445-451. doi: 10.1590/S1679
Alexiades M, Berube D. Randomized, blinded, 3-arm clinical trial assessing optimal temperature and duration for treatment with minimally invasive fractional radiofrequency. Dermatol Surg. 2015;41(5):623-32. https://doi.org/10.1097/DSS.0000000000000347
Carvalho GF, Silva RM, Mesquita Filho JJ, Meyer PF, Ronzio OA, Medeiros JO, et al. [Avaliação dos efeitos da radiofrequência no tecido conjuntivo]. Rev Bras Med. 2011;68(2,n,esp).
Slongo H, Lunardi ALB, Riccetto CLZ, Machado HC, Juliato CRT. Microablative radiofrequency versus pelvic floor muscle training for stress urinary incontinence: a randomized controlled trial. Int Urogynecol J. 2022 Jan;33(1):53-64. doi: 10.1007/s00192-021-04758-2.
Seki AS, Bianchi-Ferraro AMHM, Fonseca ESM, Sartori MGF, Girão MJBC, Jármy-Di Bella ZIK. CO2 Laser and radiofrequency compared to a sham control group in treatment of stress urinary incontinence (LARF study arm 3). A randomized controlled trial. Int Urogynecol J. 2022 Mar 7. doi: 10.1007/s00192-022-05091-y.
